Medprin Other Current Liab from 2010 to 2025

301033 Stock   43.00  0.18  0.42%   
Medprin Regenerative's Other Current Liabilities is decreasing over the years with slightly volatile fluctuation. Other Current Liabilities is expected to dwindle to about 657.1 K. From 2010 to 2025 Medprin Regenerative Other Current Liabilities quarterly data regression line had arithmetic mean of  1,207,986 and r-squared of  0.67. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
728.5 K
Current Value
657.1 K
Quarterly Volatility
444.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medprin Regenerative financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medprin Regenerative's main balance sheet or income statement drivers, such as Tax Provision of 6.1 M, Interest Income of 2.3 M or Selling General Administrative of 57.7 M, as well as many indicators such as . Medprin financial statements analysis is a perfect complement when working with Medprin Regenerative Valuation or Volatility modules.
  
This module can also supplement various Medprin Regenerative Technical models . Check out the analysis of Medprin Regenerative Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Medprin Stock

Medprin Regenerative financial ratios help investors to determine whether Medprin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medprin with respect to the benefits of owning Medprin Regenerative security.